Overwhelming Danish approval for stem cell research
This article was originally published in Clinica
Last week a large majority of the Danish parliament agreed to amend the law on artificial insemination, effectively allowing embryonic stem cell research. In its third and final reading, MPs passed the amendment that allows the research to be carried out on surplus eggs used in IVF treatment, "providing its aim is to improve the chances of effectively treating human illnesses".
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.